Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/WPD-PHARMACEUTICALS-INC-91984420/news/WPD-Pharmaceuticals-Inc-Announces-First-Patient-Dosed-in-Phase-1B-2-Clinical-Trial-of-Annamycin-42486602/?utm_source=whatsapp&utm_medium=social&utm_campaign=share